From: Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
Variable | Subgroups | Beta coefficient | 95% CI | p value |
---|---|---|---|---|
Sex | Female (Ref) | |||
Male | 0.05 | −0.2–0.3 | 0.7 | |
Age (Y) | 0.01 | −0.01–0.02 | 0.4 | |
Duration of DM (Y) | 0.01 | −0.02–0.03 | 0.2 | |
Medical history | Smoking | 0.1 | −0.06–0.25 | 0.24 |
Hypertension | 0.33 | 0.04–0.6 | 0.03* | |
Stroke | 0.1 | −0.33–0.5 | 0.7 | |
Neuropathy | 0.07 | −0.16–0.3 | 0.53 | |
Retinopathy | 0.14 | −0.1–0.4 | 0.27 | |
Medications | Insulin | 0.36 | 0.11–0.62 | <0.01* |
Metformin | −0.62 | −0.88–-0.36 | <0.01* | |
ACEIs/ARBs | −0.33 | −0.58–-0.09 | 0.01* | |
Beta blockers | 0.22 | −0.03–0.47 | 0.08 | |
CCB | 0.49 | 0.23–0.75 | <0.01* | |
Triglyceride’s level (mg/dl) | 0.02 | 0.01–0.03 | <0.01* | |
Albumin (g/dl) | −0.7 | −1.0–-0.4 | <0.01* |